Related Experiment Videos

I1 agents: a new approach to the treatment of hypertension

M Dubar¹, G Pillion

¹Institut de Recherches Internationales Servier, Courbevoie, France.

Annals of the New York Academy of Sciences

|July 12, 1995

Abstract

No abstract available in PubMed .

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

Comparison of idrabiotaparinux with vitamin K antagonists for prevention of thromboembolism in patients with atrial fibrillation: the Borealis-Atrial Fibrillation Study.

Journal of thrombosis and haemostasis : JTH·2014

Genetic polymorphisms and the impact of a higher clopidogrel dose regimen on active metabolite exposure and antiplatelet response in healthy subjects.

Clinical pharmacology and therapeutics·2011

Differential effects of omeprazole and pantoprazole on the pharmacodynamics and pharmacokinetics of clopidogrel in healthy subjects: randomized, placebo-controlled, crossover comparison studies.

Clinical pharmacology and therapeutics·2010

Antithrombotic effects of S 18886, a novel orally active thromboxane A2 receptor antagonist.

Journal of thrombosis and haemostasis : JTH·2004

Dose-effect relationship for several coagulation markers during administration of the direct thrombin inhibitor S 18326 in healthy subjects.

British journal of clinical pharmacology·2002

Rilmenidine normalizes fructose-induced insulin resistance and hypertension in rats.

Journal of hypertension. Supplement : official journal of the International Society of Hypertension·1998

See all related articles